Evidence map›Paper›PMID 38913668›Full record

ArticlePloS one2024

No detection of tick-borne encephalitis virus RNA in blood, urine or saliva of hospitalised immunocompetent tick-borne encephalitis patients.

Hanne Quarsten, Åshild K Andreassen, Katrine M Paulsen, Maria J Diekmann, Randi Eikeland, Rita Helleren, Tomas Bergström, Sølvi Noraas, Åslaug R Lorentzen

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hanne QuarstenDepartment of Medical Microbiology, Sørlandet Hospital Trust, Kristiansand, Norway.ORCID 0000-0001-6469-525X
Åshild K AndreassenDivision for Infection Control and Environmental Health, Department of Virology, Norwegian Institute of Public Health, Oslo, Norway.
Katrine M PaulsenDivision for Infection Control and Environmental Health, Department of Virology, Norwegian Institute of Public Health, Oslo, Norway.
Maria J DiekmannDivision for Infection Control and Environmental Health, Department of Virology, Norwegian Institute of Public Health, Oslo, Norway.
Randi EikelandThe Norwegian National Advisory Unit on Tick-borne Diseases, Sørlandet Hospital Trust, Kristiansand, Norway.
Rita HellerenDepartment of Clinical Medicine, Sørlandet Hospital Trust, Kristiansand, Norway.
Tomas BergströmDepartment of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Sølvi NoraasDepartment of Medical Microbiology, Sørlandet Hospital Trust, Kristiansand, Norway.
Åslaug R LorentzenThe Norwegian National Advisory Unit on Tick-borne Diseases, Sørlandet Hospital Trust, Kristiansand, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tick-borne encephalitis (TBE) is usually diagnosed based on the presence of TBE virus (TBEV)-specific IgM and IgG antibodies in serum. However, antibodies induced by vaccination or cross-reactivity to previous flavivirus infections may result in false positive TBEV serology. Detection of TBEV RNA may be an alternative diagnostic approach to detect viral presence and circumvent the diagnostic difficulties present when using serology. Viral RNA in blood is commonly detectable only in the first viremic phase usually lasting up to two weeks, and not in the second neurologic phase, when the patients contact the health care system and undergo diagnostic work-up. TBEV RNA has previously been detected in urine in a few retrospective TBE cases in the neurologic phase, and furthermore RNA of other flaviviruses has been detected in patient saliva. In this study, blood, saliva and urine were collected from 31 hospitalised immunocompetent patients with pleocytosis and symptoms of aseptic meningitis and/or encephalitis, suspected to have TBE. We wanted to pursue if molecular testing of TBEV RNA in these patient materials may be useful in the diagnostics. Eleven of the 31 study patients were diagnosed with TBE based on ELISA detection of TBEV specific IgG and IgM antibodies. None of the study patients had TBEV RNA detectable in any of the collected patient material.

Indexed as

Encephalitis, Tick-BorneEncephalitis Viruses, Tick-BorneImmunoglobulin MRNA, ViralSalivaAdultAgedAged, 80 and overAntibodies, ViralFemaleHospitalizationHumansImmunocompetenceImmunoglobulin GMaleMiddle AgedAntibodies, ViralImmunoglobulin GImmunoglobulin MRNA, Viral

Identifiers

PMID38913668
PMCPMC11195967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.